Research Topic Content {#s1}
======================

This Research Topic was organized to honor the memory of our dear friend Antonius "Ton" Rolink (April 19, 1953--August 06, 2017). The contributions are from his former students, colleagues, and collaborators. In the form of original research and review articles, these papers cover many of Ton\'s scientific interests in different aspects of lymphocyte development in mouse and man. Thus, the majority of articles concern B cell biology, ranging from papers by [Pang et al.](https://doi.org/10.3389/fimmu.2018.01264) and [Kim and Schaniel](https://doi.org/10.3389/fimmu.2018.02243) on stem cells to [Klein et al.](https://doi.org/10.3389/fimmu.2018.02258) and [Winkler and Mårtensson](https://doi.org/10.3389/fimmu.2018.02423) on B cell precursors, [Brennecke et al.](https://doi.org/10.3389/fimmu.2018.02483) and [Hobeika et al.](https://doi.org/10.3389/fimmu.2018.01806) on inducible B cell development, [Smulski and Eibel](https://doi.org/10.3389/fimmu.2018.02285) and [Kowalczyk-Quintans et al.](https://doi.org/10.3389/fimmu.2018.02698) on B cell Activating Factor (BAFF) and the impact of BIM on B cell survival, [Greaves et al.](https://doi.org/10.3389/fimmu.2018.00707) on tolerance and [Song and Matthias](https://doi.org/10.3389/fimmu.2018.02026) on the formation of germinal centers. However, Ton\'s research was also motivated by his continuous interest in T cells and graft-versus-host reactions, lymphoid tumours and in the application of antibody technology to develop novel therapeutic approaches. These subjects are covered by the contributions of [Mori and Pieters](https://doi.org/10.3389/fimmu.2018.01592) on T cells, [Calvo-Asensio et al.](https://doi.org/10.3389/fimmu.2018.01312) on T cell progenitors, by the article of [Ghia](https://doi.org/10.3389/fimmu.2018.02402) on leukemia development, by [Heiler et al.](https://doi.org/10.3389/fimmu.2018.00656) on GvH and by [Hellmann et al.](https://doi.org/10.3389/fimmu.2018.02490) on human antibody libraries.

Ton\'s Scientific Career {#s2}
========================

Ton Rolink began his scientific career as a PhD student in the group of Ernst Gleichman at the University of Amsterdam focussing on the mechanisms of T cell mediated immunopathology during Graft versus Host Disease (GvHD). This resulted in a remarkable output of 12 publications, including five in the Journal of Experimental Medicine ([@B1]--[@B12]).

In 1983, he moved to the Basel Institute of Immunology (BII) as a Scientific Member, joining the laboratory of Fritz Melchers. In the following years, the team developed the technologies and skills that led to the discovery of fundamental principles in B cell development ([@B13]--[@B16]), B cell tolerance ([@B17]) and autoimmunity ([@B18]--[@B20]). Over the years, Ton and his collaborators generated many monoclonal antibodies, some of which, including those to precursor B cells ([@B21]), the IL-5 receptor ([@B22]), CD40 ([@B23]), CD93 ([@B24]), and BAFF ([@B25]), resulted in numerous novel findings and publications.

One of the key technical advances in which Ton made a significant contribution was the establishment of stroma cell-based *in vitro* system allowing the cultivation of B cell precursors starting with single hematopoietic stem cells ([@B26]). Since Ton indeed had "green fingers" for growing cells, he was naturally gifted at cell culture. Therefore, when Stephen Nutt in Busslinger\'s laboratory showed that the transcription factor Pax5 (or BSAP) was essential for B lymphopoiesis ([@B27]) the scientific collaboration established with Ton\'s laboratory continued. This culminated in 1999 with two seminal articles in Nature describing how Pax5-deficient pro B cell lines could proceed along different developmental pathways to become antigen-presenting dendritic cells, osteoclasts, granulocytes or natural killer cells *in vitro* and to T cells following reconstitution of mice *in vivo* ([@B28], [@B29]). The realization that the transcription factor Pax5 was a master regulator of B cell development had a profound influence on the field of haematopoiesis and lymphopoiesis and opened new research avenues allowing in depth analysis of the roles of other transcription factors in the regulation of lymphocyte development ([@B30]--[@B36]).

By refining the conditions of *in vitro* B cell development, the roles of different chemokines and cytokines implicated in B cell development and homeostasis were also investigated ([@B37]--[@B41]) including the detailed dissection in mouse and man of the role of the B cell Activating Factor (BAFF) ([@B42], [@B43]) in normal B cell homeostasis and as well as in the development of autoimmunity ([@B44]--[@B47]). Using emerging molecular technologies, Ton and his group dissected B cell development at the single cell level, analysing their genotypic and transcriptomic profiles ([@B48]--[@B50]). For this, techniques capable of identifying rearrangement of D~H~ and J~H~ genes on one immunoglobulin heavy chain allele, corresponding to one molecule of rearranged DNA, could be detected ([@B51]). Without a doubt, Ton\'s research contributions were recognized world-wide and he became one of the leaders in studies of mouse and human B cell development.

Having helped to show the multi-lineage differentiation capacity of B220^+^CD117^low^CD19^−^ Pax 5 KO pro-B cell lines, Ton became interested in trying to identify a cell type with identical phenotype and equivalent differentiation capacity in the bone marrow of normal mice. This progenitor was indeed identified and referred to as an Early Progenitor with Lymphocyte and Myeloid Potential, or EPLM ([@B52]). More recent experiments using additional markers and taking advantage of single cell RNA sequencing, has revealed that the original EPLM population is both phenotypically and genotypically heterogenous with the earliest member being already committed to either lymphoid or myeloid lineages ([@B53], [@B54]).

Seeing that mice could be reconstituted with genetically-modified B cell progenitors grown *in vitro* and that Pax5 KO ([@B29]) and EPLM ([@B52]) could reconstitute the T cell compartment led Ton to expand his studies to T cell development ([@B55]). Realising that therapeutic use of progenitors grown on stromal cells would pose difficulties for clinical approval, he established stromal cell-free culture conditions whereby mouse and human T cell progenitors could be expanded and differentiated without stromal cells. The system developed was affectionately called "the plastic thymus" ([@B56]) allowing the dissection of signals involved in T cell commitment ([@B57]--[@B59]). In recent years, this led to a series of experiments investigating the possible instructive role of cytokines, in particular IL-7 and Flt3L, on lymphocyte development ([@B53], [@B60]--[@B62]).

This T cell work set the foundation for Ton\'s subsequent studies on T cell autoimmunity. Using T cell progenitors from genetically-modified mice, his group was able to expand and reconstitute the T cell compartment of immunodeficient recipients ([@B63]). However, the "plastic thymus" could not replace one of the key functions of the thymus, namely the generation of regulatory T cells ([@B64]). Without endogenous regulatory T cells, after a few weeks recipient mice reconstituted with *in vitro* generated T cell progenitors invariably developed immunopathology reminiscent of that seen in GvHD. Addition of regulatory T cells to the T progenitor inoculum was sufficient to prevent disease onset ([@B64]), providing Ton with a functional *in vivo* assay for regulatory T cell function.

Ton\'s interest in autoimmunity associated with GvHD, initiated whilst a PhD student and continued at BII and the University of Basel, interested him until the very end of his career. In his latest publications, he looked at this topic from a T-cell ([Heiler et al.](https://doi.org/10.3389/fimmu.2018.00656)) and a B-cell perspective ([@B65]). In the first, [Heiler et al.](https://doi.org/10.3389/fimmu.2018.00656) analyzed the contribution of the different T cell compartments at various stages of disease, the latter ([@B65]) showed the processes by which self-reactive antibodies might arise in aged mice.

Ton Rolink\'s key findings in the field of lymphocyte biology as well as his talent for developing numerous monoclonal antibodies and cell culture systems now used as research tools in many laboratories world-wide, were always complemented by his open, friendly, and generous personality and his infectious good humor. Throughout his scientific career, Ton worked almost daily at the bench. He was always ready to share his ideas, tools and expertise with his colleagues and collaborators, which in times of a steadily growing number of Material Transfer Agreements (MTAs), research contracts and "highly confidential information," was a rare phenomenon among scientists. Therefore, Ton will not only be remembered for his exceptional work ethic and output, but also, and maybe even more, for his exceptional way of making science fun. He will also be remembered by his colleagues and collaborators through their projects that live and thrive thanks to his reagents and spirit (Figure [1](#F1){ref-type="fig"}).

![The cartoon has been painted and kindly provided by Professor Daniela Finke, who has been for many years Ton Rolink\'s colleague at the Department of Biomedicine, University of Basel.](fimmu-09-02915-g0001){#F1}

His complete bibliography can be found in the [Appendix](#A1){ref-type="app"} and the following is a link to Ton\'s publications on PubMed: <https://www.ncbi.nlm.nih.gov/pubmed/?term=Rolink+A>.
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